Merck KGaA (MKGAF) Earnings Date, Estimates & Call Transcripts

$186.00

-7.81 (-4.03%)

(As of 09/6/2024 ET)

Stock Analysis Chart Earnings Headlines Short Interest

Latest Earnings Date: Aug. 1Estimated
Actual EPS (Aug. 1): $1.51 Beat By $1.51

MKGAF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MKGAF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Golden Crest

Biden's Successor: The Radical Threat to YOUR Savings!

Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.

>> Get Your FREE Wealth Protection Guide <<

Merck KGaA Analyst EPS Estimates

Current Year EPS Consensus Estimate:$9.50 EPS
Next Year EPS Consensus Estimate: $10.33 EPS

MKGAF Earnings Date and Information

Merck KGaA last released its quarterly earnings data on August 1st, 2024. The reported $1.51 earnings per share for the quarter. The firm had revenue of $5.76 billion for the quarter. Merck KGaA has generated $6.81 earnings per share over the last year ($6.81 diluted earnings per share) and currently has a price-to-earnings ratio of 27.3. Earnings for Merck KGaA are expected to grow by 8.74% in the coming year, from $9.50 to $10.33 per share.

Merck KGaA Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/1/2024	Q2 2024	-	$1.51	+$1.51	$1.51	-	$5.76 billion
5/15/2024	Q1 2024	$1.92	$1.74	($0.18)	$1.74	-	$5.56 billion
3/7/2024	Q4 2023	$2.15	$1.99	($0.16)	$2.53	$5.58 billion	$5.63 billion
11/9/2023	Q3 2023	-	$1.85	+$1.85	$1.85	-	$5.63 billion
8/3/2023	Q2 2023	-	$2.40	+$2.40	$3.03	-	$5.78 billion
5/10/2023	Q1 2023	-	$1.96	+$1.96	$1.96	-	$5.68 billion
Get the Latest News and Ratings for MKGAF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.
11/9/2022	Q3 2022	-	$2.70	+$2.70	$3.26	-	$5.85 billion
8/4/2022	Q2 2022	$2.53	$2.81	+$0.28	$3.50	$5.49 billion	$5.93 billion
5/12/2022	Q1 2022	-	$2.70	+$2.70	$3.13	-	$5.83 billion
11/11/2021	Q3 2021	-	$2.64	+$2.64	$3.22	-	$5.86 billion
8/5/2021	Q2 2021	-	$2.70	+$2.70	$3.34	-	$5.87 billion
5/12/2021	Q1 2021	-	$2.63	+$2.63	$3.19	-	$5.58 billion
3/4/2021	Q4 2020	-	$1.87	+$1.87	$2.55	-	$5.48 billion
11/11/2020	Q3 2020	-	$2.74	+$2.74	$3.32	-	$5.20 billion
6/30/2020	Q2 2020	-	$1.43	+$1.43	$2.12	-	$4.53 billion
5/14/2020	Q1 2020	-	$1.66	+$1.66	$2.16	-	$4.82 billion
11/8/2019	Q3 2019	-	$1.50	+$1.50	$2.12	-	$4.51 billion

Merck KGaA Earnings - Frequently Asked Questions

When did Merck KGaA announce their last quarterly earnings?: Merck KGaA (OTCMKTS:MKGAF) last announced its quarterly earning data on Thursday, August 1, 2024. Learn more on MKGAF's earnings history.
How much revenue does Merck KGaA generate each year?: Merck KGaA (OTCMKTS:MKGAF) has a recorded annual revenue of $22.72 billion.
How much profit does Merck KGaA generate each year?: Merck KGaA (OTCMKTS:MKGAF) has a recorded net income of $3.06 billion. MKGAF has generated $6.81 earnings per share over the last four quarters.
What is Merck KGaA's price-to-earnings ratio?: Merck KGaA (OTCMKTS:MKGAF) has a trailing price-to-earnings ratio of 27.31 and a forward price-to-earnings ratio of 19.58.
What is Merck KGaA's EPS forecast for next year?: Merck KGaA's earnings are expected to grow from $9.50 per share to $10.33 per share in the next year, which is a 8.74% increase.